Mr. Speaker, I appreciate the parliamentary secretary's speech today. I find it curious that, once again, we are hearing there is in fact a way for this agreement to change, that this is not the final version. What the parliamentary secretary just said was that essentially we could not sign onto investor-state provisions. That is exactly what the NDP and other parties in the House are asking for. I find it curious to hear that from the parliamentary secretary, and look forward to following up with him on that.
My question is around the cost of pharmaceuticals. Recently at the health committee our critic spoke to the assistant deputy minister for Health about the cost implications inside of CETA. She admitted at the committee that there would be a rise in cost of drugs. Where is our analysis on what this will cost Canadians, when the Liberals advocated for that in the previous Parliament, and where is the information and honesty with Canadians about the fact that drug costs will increase if we sign CETA?